Additionally, polymorphisms in C-C motif chemokine ligand 2 (CCL2) gene which codes an inflammatory or inducible chemokine and C-C motif chemokine ligand 5 (CCL5) gene which is a target of NF- B activity, have been suggested to alter the risk of post-transplant diabetes mellitus development. This evidence concerns the gene CCL2 and diabetes mellitus.